DR. LAL PATHLABS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. LAL PATHLABS Quarterly Results    (DRLP)

Here are the latest quarterly results of DR. LAL PATHLABS. For more details, see the DR. LAL PATHLABS financial fact sheet and DR. LAL PATHLABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

DR. LAL PATHLABS Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m3,2793,0172,6604,3194,5244,3106,0664,984 
Other income Rs m138120114129135135141143 
Turnover Rs m3,4173,1372,7744,4484,6594,4456,2075,127 
Expenses Rs m2,4562,4442,1773,0473,1363,0904,1763,569 
Gross profit Rs m8235734831,2721,3881,2201,8901,415 
Depreciation Rs m188200179195195203192205 
Interest Rs m3939374039444647 
Profit before tax Rs m7344543811,1661,2891,1081,7931,306 
Tax Rs m18512897295330257456343 
Profit after tax Rs m5493262848719598511,337963 
Gross profit margin %25.119.018.229.530.728.331.228.4 
Effective tax rate %25.228.225.525.325.623.225.426.3 
Net profit margin %16.710.810.720.221.219.722.019.3 
Diluted EPS Rs 6.6 3.9 3.4 10.5 11.5 10.2 16.0 11.6  
Diluted EPS (TTM) Rs 29.1 27.3 23.6 24.4 29.3 35.6 48.2 49.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: DR. LAL PATHLABS 1QFY22 Result Performance Review

More Hospital & Healthcare Services Company Quarterly Results:   BETA DRUGS   AMI ORGANICS  SUVEN LIFE SCIENCES  DENIS CHEM LAB  ALPA LAB  

Compare DR. LAL PATHLABS With:   BETA DRUGS   AMI ORGANICS  SUVEN LIFE SCIENCES  DENIS CHEM LAB  ALPA LAB  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Views on news

DR. LAL PATHLABS 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DR. LAL PATHLABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the valuation of DR. LAL PATHLABS.

DR. LAL PATHLABS Announces Quarterly Results (1QFY22); Net Profit Up 370.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, DR. LAL PATHLABS has posted a net profit of Rs 1 bn (up 370.8% YoY). Sales on the other hand came in at Rs 6 bn (up 128.0% YoY). Read on for a complete analysis of DR. LAL PATHLABS's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. LAL PATHLABS SHARE PRICE


Nov 26, 2021 (Close)

TRACK DR. LAL PATHLABS

  • Track your investment in DR. LAL PATHLABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. LAL PATHLABS

DR. LAL PATHLABS 5-YR ANALYSIS

COMPARE DR. LAL PATHLABS WITH

MARKET STATS